Weight Growth Velocity and Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants

Hidehiko Maruyama1, Naohiro Yonemoto2, Yumi Kono3

  • 1Department of Pediatrics, Kochi Health Sciences Center, Kochi, Kochi, Japan.

Plos One
|September 25, 2015
PubMed

Insights

Lower weight growth velocity (WGV) in extremely low birth weight infants (ELBWIs) is linked to poorer neurodevelopmental outcomes. Scores below 8 g/kg/day indicate higher risks, suggesting a need for improved nutritional support in NICU settings.

Area of Science:

  • Neonatalogy
  • Pediatric Neurology
  • Growth Monitoring

Background:

  • Extremely low birth weight infants (ELBWIs) face significant risks for adverse neurodevelopmental outcomes.
  • Weight growth velocity (WGV) is a critical indicator of infant health and development during the neonatal period.

Purpose of the Study:

  • To investigate the association between weight growth velocity (WGV) and neurodevelopmental outcomes in extremely low birth weight infants (ELBWIs).
  • To determine if WGV can predict neurodevelopmental impairment (NDI) or death at 3 years of age.

Main Methods:

  • A cohort of 2961 ELBWIs (birth weight 501-1000 g) from the Neonatal Research Network of Japan (2003-2007) was analyzed.
  • Patel's exponential model calculated WGV from birth to discharge.
  • Multivariate logistic regression analyzed the prediction of death or NDI at 3 years based on categorized WGV scores.

Main Results:

  • The median WGV was 10.5 g/kg/day.
  • WGV scores of 6 and 7 g/kg/day were associated with significantly increased odds of death or NDI (OR 2.41 and 1.81, respectively) compared to a reference score of 10.
  • WGV scores of 8 g/kg/day or higher did not predict death or NDI.

Conclusions:

  • Lower WGV scores (<8 g/kg/day) during NICU hospitalization are significant predictors of adverse neurodevelopmental outcomes in ELBWIs.
  • These findings highlight the importance of monitoring WGV for predicting neurodevelopmental trajectories.
  • Further research is recommended to explore nutritional interventions to improve WGV in ELBWIs.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.8K
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
2.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
467
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
782
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children...
1.1K